Back to 
UBS Group AG
UBS Group AG
FPRXShowing 0 of 10 quarters
Position history for UBS Group AG's holdings in FIVE PRIME THERAPEUTICS INC
As of its Q1 2021 13F, Ubs held 56,930 shares of FPRX (Five Prime Therapeutics), worth $2.1M. Ubs' 13F filings listed FPRX from Q1 2019 to Q1 2021, 9 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of FPRX: Magnetar Financial LLC, RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, RTW INVESTMENTS, LP